Racing Victoria stewards announce charges against six additional racing stables following detected positives for formestane, a substance used in breast cancer treatment. The stewards’ release names the trainers and stables now facing disciplinary action related to the findings. Across the reports, the new group of charges is presented as the latest development in the ongoing regulatory matter, which concerns how the drug formestane is handled under racing rules and what responses are required when it is detected. The articles state that Racing Victoria has identified this “another” set of trainers, indicating earlier charges have already been laid and that the investigation and enforcement process continues. The reporting does not describe alleged circumstances beyond the presence of formestane positives, and it does not provide outcomes of the current charges. The matter proceeds through the racing disciplinary process, with the named parties expected to respond to the charges and defend their positions if they choose.